Display search results for ** instead (19 products)
28 Dec 2015  |  Latin America
Impact and Future Direction of eHealth
While some governments in Latin America (LATAM) struggle to provide adequate basic medical supplies, others aspire to establish healthcare infrastructure that meets international standards and drives improvements in healthcare services through evidence-based medicine. In either case, healthcare information technology (healthcare IT) plays a key rol...
11 Dec 2015  |  Global
Market Due Diligence and Strategy Considerations
The US healthcare industry is undergoing a major transition toward value-based care, affecting all its stakeholders. Centers for Medicare and Medicaid Services (CMS) are steering this transition by developing policies and alternative payment models that affect all reimbursements for healthcare services. This document provides insight into CMS’s 2...
19 Oct 2015  |  North America
Creating Sustainable Strategies in an Evolving Medical Device Landscape
The medical device sector is in a transitional period where stakeholders are seeking to concurrently enact seemingly contradictory measures of improving quality of care while reducing the cost burden of that care. The key to achieving these goals includes developing strategies towards operational efficiency. This research service evaluates the curr...
30 Sep 2015  |  Europe
Changing Healthcare Dynamics Driving the M&A
The landscape of healthcare is rapidly changing worldwide as governments are reducing healthcare spending through means such as reimbursement cuts. The medical devices market bears the direct brunt of these measures. To overcome this, medical device companies are involved in active mergers and acquisitions (M&A). The study analyses the key factors ...
22 Sep 2015  |  North America
New Product Innovation Leadership - Value Based Care Administration System - GE Centricity Financial Risk Manager
A Frost & Sullivan Position Paper
Healthcare information technology systems to support provider financial management is a key area of growth and interest in the market. With shifts in models to value-based payments (VBR), this entails more financial risk for providers. Successful management of the transition to VBR can only be achieved when healthcare organizations are clinically a...
02 Sep 2015  |  North America
Analysis of Innovative and Emerging Business Models in Next Generation Healthcare
The healthcare industry is on the brink of transformation driven by a shift in the objective of care from treatment to prevention and wellness. Other major paradigm shifts such as the emergence of consumer as the center of the healthcare ecosystem and the need for delivering healthcare services at unconventional locations are creating new and excit...
20 Aug 2015  |  Asia Pacific
Major Trends in the Domestic Market
The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. The demand for immunochemistry tests in tertiary care hospitals is high. Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry ...
19 Aug 2015  |  Asia Pacific
Overview for Stakeholders
In 2014, the Australian aged care market was worth A$14 billion and is expected to grow at an annual rate of four per cent for the next five years (2015-2020). Of the total market, A$9.5 billion was provided by the federal government, while the remainder of A$4.5 billion was privately funded by companies and residents. Australian aged care systems ...
12 Aug 2015  |  North America
Analyst Insights from HIMSS 2015
The 2015 HIMSS Annual Conference and Exhibition, a key event for the health IT industry, held on April 12-16, 2015 in Chicago provided a comprehensive overview of the state of the market from the perspective of various stakeholders, including health IT vendors, healthcare providers, and government regulators, and as a reliable harbinger for what is...
USD 750.00 save 25 %
05 Jun 2015  |  North America
Driving Optimization in the Future Marketplace
The medical device supply chain is a complex and regulated system requiring increased internal and external attention. Improving efficacy and efficiency are important as manufacturing, distribution, and transportation become increasingly globalized. Market consolidation, advanced technologies, and customized cost-saving strategies will continue as ...